Pureos Bioventures

VC fundSchwyz, Switzerlandpureosbio.com

Pureos Bioventures invests in innovative drug development companies with a focus on next-generation biological drugs.

What they invest in

Stages

Series A Series B Seed

Sectors

Biotech & Pharma HealthTech

Geographies

Europe

The facts

Headquarters: Schwyz, Switzerland

Selected portfolio

AM-PharmaLava TherapeuticsVico TherapeuticsAriceumMediar TherapeuticsAcrivon Therapeutics (NAS: ACRV)ImCheck TherapeuticsTavo BiotherapeuticsMemo TherapeuticsPulseSight TherapeuticsRiver 3 RenalArarisNovaGo TherapeuticsAcrivon TherapeuticsAdcytherixAlentis TherapeuticsAM PharmaAnaCardioAraris BiotechCallio TherapeuticsCitryllCorlieve TherapeuticsEngimmune TherapeuticsEvidence Bio

and 1 more

Recent rounds

Citryll
€85MSeries BHealthTech
Forbionlead Novartis Venture FundleadPureos BioventuresDe Brabantse Ontwikkelings Maatschappij BioGeneration Ventures Seventure Partners · +3 more in the source
10 December 2024Netherlandssiliconcanals.com

Rounds Pureos Bioventures took part in, as reported by the linked articles. See who else is investing right now.

Does Pureos Bioventures fit your round?

In 30 minutes you'll know which funds matter for your round.

Book a call

Are you Pureos Bioventures? Tell us what to correct and we will update it — or ask us to remove the entry.